The correlation model of combined detection of tumor markers has not been established to evaluate its value in differential diagnosis and prediction of clinical progression in different tumor types, so it is not clear whether the combined detection of serum HMGB1 and IDO has high tissue specificity in differential diagnosis and prediction of clinical progression of ESCC. Here, HMGB1 is linked to esophageal squamous cell carcinoma.